Comparative in vitro Activities of Ceftazidime–Avibactam and Ceftolozane-tazobactam Against Characterized β-Lactamase-producing Pseudomonas aeruginosa

BACKGROUND: Ceftazidime-avibactam (CAZ-AVI) and ceftolozane-tazobactam (TOL-TAZ) are cephalosporin/β-lactamase inhibitor combinations recently approved for the treatment of complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI). Both agents are reported to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lynn-Yao, Vail, McClain, Debabov, Dmitri, Critchley, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631085/
http://dx.doi.org/10.1093/ofid/ofx163.897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631085/
http://dx.doi.org/10.1093/ofid/ofx163.897

Ejemplares similares